Neuromodulation for Tinnitus: Meta-Analysis

A new systematic review and meta-analysis of 26 randomized controlled trials has found that while several neuromodulation techniques are safe for chronic tinnitus, only one approach consistently delivered clinically meaningful and durable relief.

How the Evidence Was Evaluated

Researchers Dimitrios Kitsis, Giorgos Sideris, and Agapi Skouloudaki conducted a systematic search of three major medical databases—PubMed/MEDLINE, Web of Science, and EMBASE—for studies published between January 2015 and December 2025. They followed the PRISMA 2020 guidelines for systematic reviews to ensure a thorough and transparent process.

Their focus was on randomized controlled trials (RCTs) involving adults with chronic subjective tinnitus lasting more than three months. To be included, studies had to compare an active neuromodulation or bimodal stimulation intervention against a sham treatment or control group, and measure outcomes using validated tools like the Tinnitus Handicap Inventory (THI) or Tinnitus Functional Index (TFI). After a two-stage screening process, 26 trials involving 1,576 participants were selected for analysis. The team assessed each study’s risk of bias using the Cochrane RoB-2 tool and performed meta-analyses when at least three comparable trials were available.

Mixed Results for Traditional Neuromodulation

The review categorized the 26 trials into five intervention types. The largest groups were transcranial electrical stimulation (tES), with 11 trials, and repetitive transcranial magnetic stimulation (rTMS), with 8 trials.

When the data from multiple tDCS trials were pooled in a meta-analysis, the overall effect on tinnitus severity was not statistically significant. The standardized mean difference was -0.36, with a confidence interval crossing zero (95% CI -0.75 to 0.02). This means the observed benefit could be due to chance. Similarly, the pooled analysis for rTMS showed a non-significant effect (SMD -0.15; 95% CI -0.37 to 0.07). The evidence suggests these widely researched techniques provide, on average, a modest benefit that may not be clinically noticeable for many individuals.

Other methods fared no better. A single large trial of coordinated reset acoustic stimulation found it was no more effective than simple broadband noise. Two trials of vagus nerve stimulation (VNS) showed modest benefits, but these were associated with safety concerns, specifically for the invasive implanted devices.

Bimodal Stimulation Emerges as a Consistent Performer

The most promising findings centered on bimodal stimulation. This approach pairs auditory sounds with precisely timed, mild electrical stimulation delivered to another part of the body, typically the tongue or the neck via the vagus nerve. Four trials, involving 582 participants, tested this method.

Unlike the other modalities, bimodal stimulation yielded consistent and clinically meaningful improvements. Reductions in tinnitus severity scores often reached or exceeded 10 to 20 points on scales like the THI and TFI—a change considered significant in a patient’s daily life. Furthermore, these benefits showed durability, with studies reporting sustained relief for up to 12 months after treatment. This long-term effect is a critical metric for a chronic condition like tinnitus.

Safety and Tolerability Across the Board

A consistent positive finding was the safety profile of noninvasive neuromodulation. The review concluded that tES, rTMS, and bimodal stimulation are safe, with adverse events being predominantly mild and transient. Common side effects included temporary scalp discomfort, tingling, or mild headache. This safety record is important for patients considering these treatment options.

Practical Implications for Patients and Clinicians

For individuals seeking neuromodulation therapies, this review offers a data-driven perspective. It suggests that while tDCS and rTMS are safe, their average benefit may be limited. Bimodal stimulation appears to hold greater promise for delivering noticeable and lasting relief, making it a compelling option to discuss with a healthcare provider. The availability of these treatments varies, with some bimodal devices available for home use by prescription.

The findings also highlight the importance of managing expectations and considering the broader context of tinnitus care. As noted in related research, tinnitus is often linked to anxiety and sleep difficulties, and a holistic management plan may include behavioral strategies. Some patients find complementary practices like yoga and meditation helpful for coping with the emotional burden.

For the research community, the authors are clear: more work is needed. They call for standardized, adequately powered RCTs with harmonized protocols and long-term follow-up. This will help refine stimulation targets, dosing parameters, and identify which patients are most likely to benefit from each approach.

The study, “Effectiveness and safety of neuromodulation and bimodal stimulation for chronic subjective tinnitus: a systematic review and meta-analysis of randomized controlled trials,” provides a timely update on a fast-moving field. It underscores that not all neuromodulation is equal and points toward the techniques with the strongest evidence for helping people with chronic tinnitus.

Source: Kitsis D, Sideris G, Skouloudaki A. Effectiveness and safety of neuromodulation and bimodal stimulation for chronic subjective tinnitus: a systematic review and meta-analysis of randomized controlled trials. Laryngoscope. 2025. PMID: 42167925 | DOI: 10.1002/lary.70633